Who is sponsoring NCT03957135?

NCT03957135 is sponsored by Seoul National University Hospital.

What drugs are being tested in NCT03957135?

Interventions in NCT03957135: Laparoscopic distal pancreatectomy, open distal pancreatectomy.

What condition does NCT03957135 study?

NCT03957135 studies Pancreas Neoplasm Malignant Resectable.

Is NCT03957135 still recruiting?

NCT03957135 is currently status unknown. Last updated 21 September 2022.

Last reviewed 2022-09-21 · How we verify

NCT03957135

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Laparoscopic Versus Open Distal Pancreatectomy for Pancreatic Cancer: a Multicenter Randomized Controlled Trial

Status unknown NA Last updated 21 September 2022

What this trial tests

NA trial testing Laparoscopic distal pancreatectomy in Pancreas Neoplasm Malignant Resectable in 244 participants. Status unknown.

Timeline

20 May 2019

Primary endpoint
30 November 2025

30 November 2025

Quick facts

Lead sponsor	Seoul National University Hospital
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	244
Start date	20 May 2019
Primary completion	30 November 2025
Estimated completion	30 November 2025
Sites	1 location across South Korea

Drugs / interventions tested

Laparoscopic distal pancreatectomy
open distal pancreatectomy

Conditions studied

Pancreas Neoplasm Malignant Resectable — all drugs for Pancreas Neoplasm Malignant Resectable →

Sponsor

Seoul National University Hospital

Who can join

Adults 20 to 80, any sex, with Pancreas Neoplasm Malignant Resectable. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

When pancreatic cancer of the body and tail is diagnosed, a distal pancreatectomy is planned. This operation can be performed with open surgery, or with laparoscopic surgery. This study is a multicenter randomized controlled trial to evaluate the operative outcomes and survival of open versus laparoscopic distal pancreatectomy for pancreatic cancer of the body and tail.

Publications & conference data

5 peer-reviewed publications reference this trial (live from Europe PMC):

The Landmark Series: Minimally Invasive Pancreatic Resection.
van Hilst J, de Graaf N, Abu Hilal M, Besselink MG. · · 2021 · cited 35× · PMID 33341916 · DOI 10.1245/s10434-020-09335-3
Minimally invasive versus open pancreatic surgery: meta-analysis of randomized clinical trials.
Pfister M, Probst P, Müller PC, Antony P, et al · · 2023 · cited 25× · PMID 36967469 · DOI 10.1093/bjsopen/zrad007
Predictors for Survival in an International Cohort of Patients Undergoing Distal Pancreatectomy for Pancreatic Ductal Adenocarcinoma.
Korrel M, Lof S, van Hilst J, Alseidi A, et al · · 2021 · cited 13× · PMID 32583198 · DOI 10.1245/s10434-020-08658-5
Protocol for a randomised controlled trial to compare postoperative complications between minimally invasive and open DIStal PAnCreaTectomy (DISPACT-2 trial).
Probst P, Schuh F, Dörr-Harim C, Sander A, et al · · 2021 · cited 7× · PMID 33619204 · DOI 10.1136/bmjopen-2020-047867
Minimally Invasive versus Open Distal Pancreatectomy in the 2020s: Recent Institutional Experience and a Narrative Review of Current Evidence.
Rehman S, Patel I, Bartlett D, Mirza D. · · 2023 · cited 1× · PMID 37892716 · DOI 10.3390/jcm12206578

Verify or expand the search:

Other trials of Laparoscopic distal pancreatectomy

Trials testing the same drug.

NCT03792932 — Laparoscopic vs Open Pancreatectomy for Body and Tail Pancreatic Cancer · NA · unknown

Other Seoul National University Hospital trials

Trials by the same sponsor.

NCT07262944 — EOI Block in Otoplasty With Rib Cartilage Graft · NA · recruiting
NCT07464210 — Nemtabrutinib, Bortezomib, and Rituximab for WM · Phase 2 · not yet recruiting
NCT07550803 — Effect of Intraoperative Dexamethasone on Early Postoperative Sleep Quality in Patients Undergoing Nasal Surgery · NA · not yet recruiting
NCT07522138 — Home-based Self-exercise in Patients With Parkinson's Disease: A Feasibility Study · NA · not yet recruiting
NCT07476651 — Scout Dose of Resin Microspheres · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03957135 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Seoul National University Hospital
Last refreshed: 21 September 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03957135.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing